FDAnews
www.fdanews.com/articles/183713-recall-issued-for-spectranetics-bridge-catheter
Recall stamp

Recall Issued for Spectranetics Bridge Catheter

September 27, 2017

Spectranetics issued a recall for its Bridge catheter for possible inability to pass the guidewire through the device, resulting in a potential delay of treatment. The FDA determined the cause to be a nonconforming material/component.

The device is used for temporary vessel occlusion of the superior vena cava in applications including perioperative occlusion and emergency control of hemorrhage.

Spectranetics mailed a recall letter to customers on Aug. 8, and an updated letter on Aug. 23.

View today's stories